Literature DB >> 33964329

Extended dosing intervals of ixekizumab for psoriasis: A single-center, uncontrolled, prospective study.

Li-Ran Ye1, Bing-Xi Yan1, Xue-Yan Chen1, Si-Qi Chen1, Jia-Qi Chen2, Xiao-Yong Man3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33964329     DOI： 10.1016/j.jaad.2021.04.093

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group.

Authors:  Yu-Xin Zheng; Li-Ran Ye; Bing-Xi Yan; Si-Qi Chen; Sui-Qing Cai; Xiao-Yong Man
Journal:  Front Med (Lausanne)       Date:  2022-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.